Lysosomal Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Lysosomal Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2019.
Lysosomal Therapeutics at a glance
What does Lysosomal Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1 million sold (2019).
Frequently asked questions about Lysosomal Therapeutics
Where is Lysosomal Therapeutics headquartered?
Lysosomal Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Lysosomal Therapeutics do?
Lysosomal Therapeutics, Inc. is a pharmaceutical company.
When was Lysosomal Therapeutics founded?
The earliest incorporation on record for Lysosomal Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences